Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Neoplasms 1Lymphoma, Follicular 1Hypertension 1Heart Failure 1

Interventions

relacorilant 3Osilodrostat 2sacubitril and valsartan sodium hydrate drug combination 1lutetium Lu 177 dotatate 1gallium Ga 68 dotatate 1enzalutamide 1bicalutamide 1Urine Specimen Collection 1Surveys and Questionnaires 1Standard of Care 1Receptors, Androgen 1Nutrition Assessment 1Leuprolide 1Interviews as Topic 1Holistic Health 1Goserelin 1Flutamide 1Blood Specimen Collection 1Biopsy 1Amlodipine 1Adrenalectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hypertension × sacubitril and valsartan sodium hydrate drug combination × 1 year × Clear all
NCT06236061 2026-01-13

Study of Efficacy and Safety of LCZ696/Amlodipine in Grade 1 and 2 Hypertension Patients Uncontrolled by LCZ696 Monotherapy

Novartis

Phase 3 Completed
718 enrolled
Lymphoid

Hypertension, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡